User profiles for Pedro Ballesteros
 | PEDRO PABLO BALLESTEROS SILVAPhD en Ingeniería, Profesor de Administración de Operaciones, Logística, Estadistica … Verified email at utp.edu.co Cited by 1368 |
[HTML][HTML] Post-COVID-19-associated morbidity in children, adolescents, and adults: a matched cohort study including more than 157,000 individuals with COVID-19 in …
…, D Hertle, S Scholz, S Stern, P Ballesteros… - PLoS …, 2022 - journals.plos.org
Background Long-term health sequelae of the Coronavirus Disease 2019 (COVID-19) are a
major public health concern. However, evidence on post-acute COVID-19 syndrome (post-…
major public health concern. However, evidence on post-acute COVID-19 syndrome (post-…
[HTML][HTML] Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study
…, C Schulte, T Buschmann, D Hertle, P Ballesteros… - Clinical …, 2023 - Springer
Objectives To investigate whether the risk of developing an incident autoimmune disease is
increased in patients with prior COVID-19 disease compared to those without COVID-19, a …
increased in patients with prior COVID-19 disease compared to those without COVID-19, a …
Post COVID-19 in children, adolescents, and adults: results of a matched cohort study including more than 150,000 individuals with COVID-19
…, D Hertle, S Scholz, S Stern, P Ballesteros… - MedRxiv, 2021 - medrxiv.org
Background Long-term health sequelae of the coronavirus disease 2019 (COVID-19) are a
major public health concern. However, evidence on post-acute COVID-19 syndrome (post …
major public health concern. However, evidence on post-acute COVID-19 syndrome (post …
Large cohort study shows increased risk of developing atopic dermatitis after COVID-19 disease
…, T Buschmann, D Hertle, P Ballesteros… - …, 2024 - pubmed.ncbi.nlm.nih.gov
… 3 , Pedro Ballesteros …
[HTML][HTML] Development of a risk score to identify patients at high risk for a severe course of COVID-19
…, D Hertle, S Scholz, S Stern, P Ballesteros… - Journal of Public …, 2023 - Springer
Aim We aimed to develop a risk score to calculate a person’s individual risk for a severe
COVID-19 course (POINTED score) to support prioritization of especially vulnerable patients for …
COVID-19 course (POINTED score) to support prioritization of especially vulnerable patients for …
[HTML][HTML] Optimising the impact of COVID-19 vaccination on mortality and hospitalisations using an individual additive risk measuring approach based on a risk …
D Wende, D Hertle, C Schulte, P Ballesteros… - The European Journal of …, 2022 - Springer
In this population-based cohort study, billing data from German statutory health insurance (BARMER,
10% of population) are used to develop a prioritisation model for COVID-19 …
10% of population) are used to develop a prioritisation model for COVID-19 …
Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study
S Morales, A Lorenzo, M Ramos, P Ballesteros… - Cancer chemotherapy …, 2004 - Springer
Purpose: In this multicentre phase II study, the efficacy and safety profile of the combination
of docetaxel and epirubicin as first-line chemotherapy for metastatic breast cancer (MBC) …
of docetaxel and epirubicin as first-line chemotherapy for metastatic breast cancer (MBC) …
[PDF][PDF] Planeación estratégica logística para un holding empresarial
SE Mejía, PP BALLESTEROS - Scientia et technica, 2010 - redalyc.org
Este trabajo presenta el desarrollo de un modelo de planeación logística para una organización
formal. El modelo recopila el direccionamiento estratégico de la empresa en el cual se …
formal. El modelo recopila el direccionamiento estratégico de la empresa en el cual se …
Correction to: incident autoimmune diseases in association with SARS-Cov-2 infection: A matched cohort study
…, T Buschmann, D Hertle, P Ballesteros… - Clinical …, 2023 - ncbi.nlm.nih.gov
… Falko Tesch, corresponding author 1 Franz Ehm, 1 Annika Vivirito, 2 Danny Wende, 3
Manuel Batram, 4 Friedrich Loser, 5 Simone Menzer, 6 Josephine Jacob, 2 Martin Roessler …
Manuel Batram, 4 Friedrich Loser, 5 Simone Menzer, 6 Josephine Jacob, 2 Martin Roessler …
Hierarchisierung von Risikofaktoren für schwere COVID-19-Erkrankungsverläufe im Kontext der COVID-19-Schutzimpfungen
…, R Jucknewitz, O Weidinger, M Batram, P Ballesteros… - 2021 - edoc.rki.de
Angesichts der derzeitigen Impfstoffknappheit geht mit den bundesweiten Schutzimpfungen
gegen COVID-19 die Notwendigkeit einer Priorisierung bestimmter Bevölkerungsgruppen …
gegen COVID-19 die Notwendigkeit einer Priorisierung bestimmter Bevölkerungsgruppen …